Pharmacy Chain 36.6. Financial results for nine months of 200623.11.2006 NOVEMBER 23, 2006, MOSCOW – Pharmacy Chain 36.6 [MICEX: RU14APTK1007; RTS: APTK] announces its unaudited financial results for 9M 2006 according to International Financial Reporting Standards (IFRS). Sales- Consolidated sales for 9M 2006 increased by 64.6% y-o-y and reached $346.9 million.
- Sales in the retail segment grew by 77.3% in 9M 2006. During the period 48 pharmacies were organically opened and 12 regional pharmacy chains included 264 pharmacies were acquired. Same store sales in the chain’s pharmacies opened or acquired before October 1, 2005 were up by 20.6%.
- Veropharm’s sales for 9M 2006 reached $70.7 million, representing an increase of 26.8% y-o-y.
Profit- Consolidated gross profit for 9M 2006 increased by 49.1% y-o-y and reached $121.8 million. Pharmacy Chain 36.6’sincreased share of regional operations is pulling down the gross margin to 35.1% in 9M 2006.
- The Company’s consolidated EBITDA decreased by 17.6% to $12.3 million. Growth in SG&A expenses by 62.5% y-o-y impacts on the EBITDA level.
- Net profit totalled $41.5 million in 9M 2006 resulting from the sale to the market of 30% of the Veropharm shares.
Debt- In 9M 2006 Pharmacy Chain 36.6 credit portfolio reached $196 million.
| 
